MIRARHINE - 50
Shipping calculated at checkout.
Quantity
Each Film Coated Prolonged Release Tablet Contains: Mirabegron 50 mg Excipients q.s
In the management of OAB
Mirabegron 50mg Tablets
• Proven efficacy and excellent tolerability in patients ≥75 years.
* Superior 12 months treatment persistence and adherence compared to anti-muscaranics.
Lower dementia risk compared to anti-cholinergics.
• AUA/SUFA: dementia risk increase after 3+ months of anti-cholinergics.
Patients with inadequate response to current regimens
Newly diagnosed patients focused on QoL
Elderly patients with unique treatment needs
Mirabegron 50mg Tablets
